Welcome to LookChem.com Sign In|Join Free

CAS

  • or

87-89-8

Post Buying Request

87-89-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

87-89-8 Usage

Vitamin B class

Inositol belongs to the vitamins B class. Because of the different orientation of the relative ring plane of hydroxyl, it has a total of nine kinds of isomers, including 7 of non-optically active form, two kinds of optically active (L-form and D-form). In nature, it is widely distributed in all living tissues as either free or bound state, and is a common component presented in animal and plant cells. It can be synthesized by gastrointestinal microbes, being involved in carbohydrate and lipid metabolism in the body. It is mainly presented in the form of phosphatidylinositol in animal. It is most abundant in brain, heart and skeletal muscle. It is mainly in the form inositol phosphate in plants, and can bind with calcium, zinc and iron into insoluble compounds, which interfere with their digestion and absorption. Lack of inositol in daily diet can cause hair loss, and negatively affect development. Inositol is related to the intracellular calcium metabolism where its triphosphate derivative can be released from lipid conjugate after cell is stimulated, thus playing a role of secondary messenger. This process can mobilize the intracellular calcium pool to participate in regulation of many cellular events, e.g. secretion, metabolism, cell division, and light transmission. Inositol is often clinically used together with vitamin B complex, which can prevent or reduce the deposition of excess fat in the liver, and thus promoting the liver fat metabolism. This has a effect on reducing blood lipids, and removing the infiltration effect of the liver cells’ fat. It can be used for treatment of fatty liver, alcohol liver disease, atherosclerosis, high blood cholesterol, diabetes, alopecia, hyperlipidemia and so on. Its derivatives, such as phosphatidylinositol is one of the components of the cell membrane. Phytate (phytic acid) or phytin (phytin) often accumulated in seeds of higher plants. Phytic acid extracted from rice bran or bran can be used as food antioxidants, stabilizers and preservatives. Since the vast majority of animals and their gastrointestinal microbes can synthesize enough inositol, and food is abundant of inositol, so there are rare cases of inositol deficiency. Many kinds of fish and female gerbils cannot synthesize inositol (The testis tissue of male gerbil can synthesize inositol). Dietary phthaloyl Sulfathiazole can inhibit bacterial synthesis of inositol , which leads to rats’ deficiency of inositol, as follows: the content of free inositol in rat testis, liver, heart, kidney and plasma reduces; Hair loss and dermatitis happens; The content of triglycerides, cholesterol esters in liver increases; Both the size and number of lipid droplets increased significantly; There are also occurrence of fatty liver which can be healed by taking inositol; Moreover, the transport capacity of intestinal mucosal cell for the saturated fat cells decreases , and there is accumulation of intestinal fat. The performance of inositol deficiency for fish is as below: fins degeneration, edema, anemia, decreased gastric emptying rate, and decreased activity of cholinesterase and some transaminase. The above information is edited by the lookchem of Dai Xiongfeng.

Identification test

Take 1 mL 2% sample solution to a porcelain evaporating dish, add 6ml nitric acid and evaporated to dryness on a water bath. The residue is dissolved with 1mL of water. Add 0.5 mL 10% strontium acetate solution and evaporate it to dryness on a steam bath again. It should display purple.

Content Analysis

Accurately weigh 200 mg sample (pre-dried at 105°C for 4h), and place it into a 250ml beaker. Add 5ml of a mixture between one sulfuric acid (TS-241) testing solution and 50 acetic anhydride, and then cover the watch glass. After heating on a steam bath for 20min, cool it on an ice bath, add 100ml water, and boil 20min. After cooling, transfer the sample into a 250 mL separating funnel using a small amount of water. Successively use 30, 25, 20, 15, 10 and 5 mL of chloroform to extract the solution for six times (first flush the beaker). All the chloroform extract was collected in a second 250m1 separating funnel. Wash the mixed extract with 10ml of water. Put the chloroform solution through a funnel cotton wool and transfer it to a 150ml pre-weighed Soxhlet flask. Use 10ml of chloroform to wash the separating funnel and the funnel, and incorporated into the extract. Evaporate it to dryness on a steam bath, and then transfer it in an oven at 105 °C for drying 1h. Cool it in a desiccator, and weigh it. Use the obtained amount of six inositol acetate multiply by 0.4167, namely the corresponding amount of inositol (C6H12O6).

Toxicity

GRAS (FDA, §182.5370, 2000).

Limited usage

No restrictions (FDA§184.1370,2000). GB 14880-94 states: infant food, fortified beverages 210~230mg/kg. GB 2760-2002: Juices (fruit) drinks, 60~120mg/kg.

Chemical Properties

Different sources of media describe the Chemical Properties of 87-89-8 differently. You can refer to the following data:
1. White crystal or crystalline powder, odorless, and sweet; Relative density: 1.752 (anhydrous), 1.524(dihydrate), m.p. 225~227 ℃ (anhydrous), 218 °C (dihydrate), boiling point 319 °C. Dissolved in water (25 °C, 14g/100mL; 60 °C, 28g/100mL), slightly soluble in ethanol, acetic acid, ethylene glycol and glycerol, insoluble in ether, acetone and chloroform. Stable in air; Stable to heat, acid and alkali, but is hygroscopic.
2. white powder

Uses

Different sources of media describe the Uses of 87-89-8 differently. You can refer to the following data:
1. 1. As food supplements, has a similar effect to vitamin B1. It can be used for infant foods and used in an amount of 210~250mg/kg; Used in drinking in an amount of 25~30mg/kg. 2. Inositol is an indispensible vitamin for lipid metabolism in the body. It can promote the absorption of hypolipidemic medicines and vitamins. Moreover, it can promote the cell growth and fat metabolism in liver and other tissues. It can be used for the adjuvant treatment of fatty liver, high cholesterol. It is widely used in food and feed additives, and is often added to fish, shrimp and livestock feed. The amount is 350-500mg/kg. 3. The product is one kind of the complex vitamin B, which can promote cell metabolism, improve the cell nutrient conditions, and can contribute to development, increase appetite, to recuperate. Moreover, it can prevent the accumulation of fat in the liver, and accelerate the process of removing excess fat in heart. It has a similar lipid-chemotactic action as choline, and therefore useful in the treatment of hepatic fatty excessive disease and cirrhosis of the liver disease. According to the "food fortifier use of health standards (1993)" (Issued by the Ministry of Health of China), it can be used for infant food and fortified beverages at an amount of 380-790mg/kg. It is a vitamin class medicines and lipid-lowering drug which promote the fat metabolism of liver and other tissues, and be useful for the adjuvant treatment of fatty liver and high cholesterol. It is widely used in additives of food and beverage. 4. Inositol is widely used in pharmaceutical, chemical, food, etc. It has a good effect on treating diseases such as liver cirrhosis. It can also used for advanced cosmetic raw materials, with high economic value. 5. It can be used as a biochemical reagent and also for the pharmaceutical and organic synthesis; It can lower the level cholesterol and have sedative effect.
2. Myo-Inositol is a growth factor for animals and microorganisms. It is the most abundant form of polyols that serves as a structural element of secondary messengers in eukaryotic cells. It is used as an adulterant in many illegal drugs like cocaine and methamphetamine. Further, it is used as a stand-in for cocaine on television and film.
3. The structural basis for a number of signaling and secondary messenger molecules including; insulin signal transduction, cytoskeleton assembly, nerve guidance, membrane potentials, serotonin activity and the breaking down of fats and reducing cholesterol.
4. lipotropic agent
5. A growth-factor and structural element of secondary messengers in eukaryotic cells

Production method

1. It is produced by the hydrolysis and the following neutralization of phytin. Add phytin and water into high-pressure hydrolysis pot, seal and heat until pressure gradually rise to around 0.5 MPa; stir for 8 h; check the pH value of the material which should be 2.5-3.0 as the end of the reaction. Add the hydrolyzed liquid into neutralized pot with the milk of lime for neutralization agent. Keep the temperature at 70-80 °C, and the pH value at 7-8. Use centrifuge to throw out filtrate. The Residue can be used for fertilizer (calcium phosphate). Heat the above filtrate to 80-90 °C, put 0.5-0.7% activated carbon, and stir continuously for about 20 min. Use sand core hold for suction filtration. The filtered supernatant is concentrated into condensed pot for condensation for 4-5h at 90 °C. The material can be taken out when the relative density reaches 1.24-1.28, then add enamel barrels or stainless steel barrel for cooling. When the crystal appears, artificially stir and cool to 20-25 °C, send into the centrifuge for drying and obtain the yellow crude product of inositol. Throw out the crude stock solution for another round of condensation and crystallization. Add water or line liquid to the crude product, dissolve it by heating, add active carbon for decoloration; Then add solution of barium oxide and ammonium oxalate to precipitate and remove the sulfate and calcium ions. Filter (when the mixture is still hot) and the filtrate was cooled to 30 °C, crystallize, filter (liquor apply), wash the filtered pellet with ethanol, dry at 80 °C for 6h, and finally go through 18 mesh sieve to obtain inositol. 2. Production Method (1) Sock 1 part of bran meal and 10 parts of water into the immersion pool, Use hydrochloric acid or sulfuric acid to adjust pH till 2.5-3.0, then soak 4-8h at room temperature (longer for winter, shorter for summer). In this case, the insoluble potassium, calcium and magnesium complex salts of plant acid in bran meal are converted into soluble complex salts. Filter and wash the residue with water. The residues can be used for feed. Mix the filtrate and washings and stir using compressed air, then add fresh lime milk to neutralize till pH 6.8. The neutralized mixture was allowed to stand for 2h for thoroughly calcium phytate precipitation. Suck out the supernatant in the upper layer, add clean water to wash repeatedly until washing liquid does not exhibit light yellow (neutral). Apply filter press to filter the lower layer of white slurry to obtain pasty-calcium phytic acid namely phytin. Pour paste phytin and water into high pressure hydrolysis pot for mashing. The concentration should be kept at 25%, and heated to an internal pressure 0.5 MPa, Stirring reaction should be kept for 8h with the pH 2.5-3.0. Add hydrolysis solution into neutralization pot, and neutralize at 70-80 °C with lime milk to pH 7-8. Filter and remove the residue which can be used for fertilizer. Adding catalyst can reduce the reaction temperature and shorten the reaction time. Heat the hydrolysis solution to 80-90 °C, add 0.5%-0.7% of activated carbon, filter after decoloration. Condense the filtrate for 4-5 hour at 90 °C. Take the materials out when the relative density reaches 1.24-1.28. Cool it to 20-25 °C and crystallize to isolate the yellow inositol crude. Condense and crystallize the filtrate again. Heat the crude product and dissolve in water. Add active carbon for decolorization. Add barium hydroxide solution and ammonium oxalate solution to precipitate and remove the sulfate and calcium ions. Filter (when the mixture is still hot) and the filtrate was cooled to 30 °C, crystallize, filter (liquor apply), wash the filtered pellet with ethanol, dry at 80 °C for 6h, and finally go through 18 mesh sieve to obtain inositol. (2) Use the bran as raw material. Soaked it at 30 °C using 1%-1.5% hydrochloric acid for 4-8h, filter it through a plate and frame filter press. Soak the residue for 2 times and neutralize the filtrate with milk of lime until PH value = 7, stir thoroughly for 10min, filter, wash to get the crude product of phytate. The crude product is then dissolved in hydrochloric acid solution (pH = 1-2) and subject to decoloration and filter by activated carbon. Adjust the pH filtrate to pH= 4.5 using 10% Na2CO3 solution stir for 10min, stand for 1-1.5h. Discard the upper layer of supernatant. Place the slurry of calcium phytic acid into a pressure cooker with the subsequent process the same as above.

Description

Inositol (hexahydroxycyclohexane) is a widely distributed natural constituent of plant and animal tissues. The animal tissues richest in inositol are brain, heart, stomach, kidney, spleen, and liver, where it occurs free or as a component of phospholipids. Among plants, cereals are rich sources of inositol, particularly in the form of polyphosphoric acid esters, called phytic acids. Although there are several possible optically active and inactive isomers, considerations of inositol as a food additive refer specifically to optically inactive cis-1,2,3,5-trans-4,6-cyclohexanehexol, which is preferably designated myo-inositol. Pure inositol is a stable, white, sweet, crystalline compound. The Food Chemicals Codex specifies that it assay not less than 97.0 percent, melt between 224 and 227°, and contain not more than 3 ppm arsenic, 10 ppm lead, 20 ppm heavy metals (as Pb), 60 ppm sulfate, and 50 ppm chloride. Inositol was thought for a time to be a vitamin because experimental animals on a synthetic diet developed clinical signs that were corrected by inositol supplementation. However, no cofactor or catalytic function for inositol has been found; it can be synthesized and occurs in relatively high concentration in animal tissues. These factors argue against its classification as a vitamin. A dietary requirement in man has not been established.

Originator

Inositol,Comm. Solvents,US,1949

Definition

ChEBI: An inositol having myo- configuration.

Manufacturing Process

Inactive inositol may be prepared from starch factory steep water which is the liquid in which corn is steeped to soften the covering of the corn kernel and to thoroughly soften the entire kernel. It contains approximately 1% sulfurous acid (H2SO3) in solution. A typical example of such treatment consists in adding to the acid steep water, lime Ca(OH)2 or CaO to approximate neutrality, or to a pH of 6.0 to 8.0, at which range the insoluble "phytin" is precipitated. This precipitate of impure "phytin" or calcium phytate is removed by suitable means, as stated before, and may be mixed with (1) 1 to 10% acid solution; or (2) diluted with water; or (3) the solution may be made alkaline. This alkaline or neutral or acid mixture is placed in a suitable container in an autoclave or steam digester, and the steam turned on whereupon the reaction is allowed to proceed as long as desired. The autoclave in which the mixture has been placed may be heated by generating steam therein, by means of an electric heater, or by suitable heat from outside. A pressure of from 1 to 200 pounds steam for 1 to 18 hours may be used, the time required being correspondingly less for higher pressures. A suitable pressure is 80 pounds. The time expected for 80 pounds is three hours.autoclave cooled, the mixture removed, diluted, and made alkaline with Ca(OH)2, Ba(OH)2,etc., brought to boiling, thoroughly agitated with steam, the insoluble sludge allowed to settle, and the supernatant liquid removed by decantation, siphoning or filtration. The supernatant liquid is concentrated in an open vessel, or in vacuum, to remove the precipitating inorganic impurities as calcium carbonate (CaCO3), magnesium carbonate (MgCO3), etc. The liquid is concentrated until it becomes thick and syrupy. The concentrated solution is filtered, cooled, and agitated by a suitable mechanical means to precipitate iinositol. The iI-inositol is removed by filtration, the mother liquor concentrated, and the process repeated until the solution becomes too thick to filter advantageously. A filter press may be employed to remove furtherquantities of i-inositol, or the thick residue may be diluted with a reagent in which i-inositol is insoluble; as, for example, acetic acid (CH3COOH) and alcohol-acetic acid (C2H5OH, CH3COOH, etc.). On cooling and stirring the solution, additional i-inositol, etc., results and can be removed by filtration or other mechanical means. The i-inositol may be recrystallized by dissolving the crude product in boiling water, and reprecipitated by cooling and stirring. The final crystallization from a hot water solution to which an equal volume of alcohol is added with cooling and stirring, gives a purer product.

Therapeutic Function

Vitamin, Lipotropic

General Description

Myoinositol is a stereoisomeric form of inositol, and is very often found in many plants and in tissues of animals and plants. It acts as a second messenger, thereby is very important for the signal pathways of cells. It generally finds application in being used as a natural insulin sensitizer in PCOS (Polycystic Ovarian Syndrome) patients. Myoinositol acts in a PCOS pathway by improving insulin sensitivity, thereby sequentially increasing intracellular glucose uptake.

Biochem/physiol Actions

A component of membrane phospholipids, glycosyl-phosphatidyl-inositol anchors that bind glycoproteins to cell membranes, and inositol phosphate second messengers.

Purification Methods

Recrystallise myo-inositol from aqueous 50% ethanol or H2O forming a dihydrate, or anhydrous crystals from AcOH. The dihydrate is efflorescent and becomes anhydrous when heated at 100o . The anhydrous crystals are not hygroscopic. Its solubility in H2O at 25o is 14%, at 60o it is 28%; it is slightly soluble in EtOH but insoluble in Et2O. [Ballou & Anderson J Am Chem Soc 7 5 748 1953, Anderson & Wallis J Am Chem Soc 70 2931 1948, Beilstein 6 II 1157, 6 IV 7919.]

Check Digit Verification of cas no

The CAS Registry Mumber 87-89-8 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 8 and 7 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 87-89:
(4*8)+(3*7)+(2*8)+(1*9)=78
78 % 10 = 8
So 87-89-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3-,4+,5-,6-

87-89-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A13586)  myo-Inositol, 98+%   

  • 87-89-8

  • 100g

  • 239.0CNY

  • Detail
  • Alfa Aesar

  • (A13586)  myo-Inositol, 98+%   

  • 87-89-8

  • 500g

  • 955.0CNY

  • Detail
  • Alfa Aesar

  • (A13586)  myo-Inositol, 98+%   

  • 87-89-8

  • 2500g

  • 4046.0CNY

  • Detail
  • Sigma-Aldrich

  • (57570)  myo-Inositol  for microbiology, ≥99.0%

  • 87-89-8

  • 57570-25G

  • 379.08CNY

  • Detail
  • Sigma-Aldrich

  • (57570)  myo-Inositol  for microbiology, ≥99.0%

  • 87-89-8

  • 57570-100G

  • 960.57CNY

  • Detail
  • Sigma-Aldrich

  • (57570)  myo-Inositol  for microbiology, ≥99.0%

  • 87-89-8

  • 57570-500G

  • 3,704.22CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1351)  Inositol  pharmaceutical secondary standand; traceable to USP and PhEur

  • 87-89-8

  • PHR1351-1G

  • 732.19CNY

  • Detail
  • Sigma-Aldrich

  • (Y0000485)  myo-Inositol  European Pharmacopoeia (EP) Reference Standard

  • 87-89-8

  • Y0000485

  • 1,880.19CNY

  • Detail
  • USP

  • (1340960)  Inositol  United States Pharmacopeia (USP) Reference Standard

  • 87-89-8

  • 1340960-500MG

  • 4,662.45CNY

  • Detail
  • Sigma

  • (I5125)  myo-Inositol  ≥99%

  • 87-89-8

  • I5125-10MG

  • 242.19CNY

  • Detail
  • Sigma

  • (I5125)  myo-Inositol  ≥99%

  • 87-89-8

  • I5125-50G

  • 458.64CNY

  • Detail
  • Sigma

  • (I5125)  myo-Inositol  ≥99%

  • 87-89-8

  • I5125-100G

  • 816.66CNY

  • Detail

87-89-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name myo-inositol

1.2 Other means of identification

Product number -
Other names bios I

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:87-89-8 SDS

87-89-8Synthetic route

(+/-)-1,2:4,5-di-O-isopropylidene-myo-inositol
51548-88-0, 96039-15-5, 98974-89-1, 128110-25-8

(+/-)-1,2:4,5-di-O-isopropylidene-myo-inositol

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
palladium dihydroxide In methanol for 88h; Heating;97%
2,4,6-tri-O-benzyl-1,3,5-O-orthoformate-D-myo-inositol

2,4,6-tri-O-benzyl-1,3,5-O-orthoformate-D-myo-inositol

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
palladium dihydroxide In methanol for 72h; Heating;96%
With Pd(OH)2/C In methanol for 72h; Reflux;
(±)-2,3:5,6-di-O-isopropylidene-1,4-di-O-benzyl-myo-inositol

(±)-2,3:5,6-di-O-isopropylidene-1,4-di-O-benzyl-myo-inositol

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
palladium dihydroxide In methanol for 22h; Heating;95%
1D-1-O-Acetyl-myo-inositol

1D-1-O-Acetyl-myo-inositol

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
With sodium methylate In methanol at 70℃; for 3h; Deacetylation;94%
2-O-tert-butyldimethyl-myo-inositol 4,6-carbonate 1,3,5-orthoformate

2-O-tert-butyldimethyl-myo-inositol 4,6-carbonate 1,3,5-orthoformate

A

D-myo-inositol
87-89-8

D-myo-inositol

B

myo-inositol 4,6-carbonate

myo-inositol 4,6-carbonate

Conditions
ConditionsYield
With water; trifluoroacetic acid at 65 - 70℃;A n/a
B 83%
2-O-(tert-butyldimethylsilyl)-4,6-O-methylene-myo-inositol 1,3,5-orthoformate

2-O-(tert-butyldimethylsilyl)-4,6-O-methylene-myo-inositol 1,3,5-orthoformate

A

D-myo-inositol
87-89-8

D-myo-inositol

B

4,6-O-methylene-myo-inositol
1259936-03-2

4,6-O-methylene-myo-inositol

Conditions
ConditionsYield
With methanol; toluene-4-sulfonic acid In chloroform at 40℃; for 48h;A n/a
B 74%
myo-inositol 1-phosphate
15421-51-9

myo-inositol 1-phosphate

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
With alkaline phosphatase type III from Escherichia coli In various solvent(s) at 25℃; for 16h; pH=8.0; Substitution;63.6%
inositol peracetate
1254-38-2

inositol peracetate

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
With hydrogenchloride
With sodium methylate In methanol for 2h;
benzenehexol
608-80-0

benzenehexol

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
With water; hydrogen; palladium at 50 - 55℃;
With ethanol; nickel at 125℃; under 95616 Torr; Hydrogenation;
With water; palladium at 20℃; Hydrogenation.sowie bei 55grad;
sequoyitol
523-92-2

sequoyitol

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
With hydrogen iodide
With hydrogen iodide Heating;0.08 g
(+)-Conduritol E epoxide
145107-29-5

(+)-Conduritol E epoxide

A

D-myo-inositol
87-89-8

D-myo-inositol

B

allo-inositol
643-10-7

allo-inositol

Conditions
ConditionsYield
With barium dihydroxide
Conditions
ConditionsYield
In water for 48h; Product distribution; biosynthesis with Simmondsia chinensis, various time;
(1R)-1-L-O-methyl-myo-inositol
22350-68-1

(1R)-1-L-O-methyl-myo-inositol

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
With hydrogen iodide In water for 1h; Heating;0.1 g
With water Reflux;
D-Myo-inositol-1-monophosphate
93712-94-8

D-Myo-inositol-1-monophosphate

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
In water at 40℃; rice bran acid phosphatase, 0.2 M acetate buffer;
Myo-inositol-2-monophosphate
93712-94-8

Myo-inositol-2-monophosphate

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
In water at 40℃; rice bran acid phosphatase, 0.2 M acetate buffer;
L-Myo-inositol-3-monophosphate
93712-94-8

L-Myo-inositol-3-monophosphate

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
In water at 40℃; rice bran acid phosphatase, 0.2 M acetate buffer;
1,2:4,5-Dianhydro-cis-inosit
50474-02-7

1,2:4,5-Dianhydro-cis-inosit

A

D-myo-inositol
87-89-8

D-myo-inositol

B

muco-inositol
488-55-1

muco-inositol

Conditions
ConditionsYield
With sulfuric acid for 3h; Heating;A 14 % Spectr.
B 86 % Spectr.

A

D-myo-inositol
87-89-8

D-myo-inositol

B

muco-inositol
488-55-1

muco-inositol

C

myo-inositol
488-59-5

myo-inositol

chiro-inositol
18685-70-6

chiro-inositol

Conditions
ConditionsYield
With sulfuric acid for 3h; Heating;A 0.5 % Spectr.
B 80 % Spectr.
C 0.5 % Spectr.
D 19 % Spectr.
(1S,2R,3R,4R)-3,4-O-Isopropylidenecyclohex-5-ene-1,2,3,4-tetraol
139013-60-8

(1S,2R,3R,4R)-3,4-O-Isopropylidenecyclohex-5-ene-1,2,3,4-tetraol

A

D-myo-inositol
87-89-8

D-myo-inositol

B

muco-inositol
488-55-1

muco-inositol

Conditions
ConditionsYield
With sulfuric acid; 3-chloro-benzenecarboperoxoic acid 1.) CH2Cl2; Yield given. Multistep reaction. Yields of byproduct given;
D-myo-inositol-3-phosphate
2831-74-5

D-myo-inositol-3-phosphate

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
With pAD1.88A; phosphatse from Escherichia coli JWF1
(+)-Conduritol E epoxide
145107-29-5

(+)-Conduritol E epoxide

aqueous barium hydroxide

aqueous barium hydroxide

A

D-myo-inositol
87-89-8

D-myo-inositol

B

allo-inositol
643-10-7

allo-inositol

Conditions
ConditionsYield
at 100℃;
2.3.5.6-tetrahydroxy-benzoquinone-(1.4)

2.3.5.6-tetrahydroxy-benzoquinone-(1.4)

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
With water; palladium at 20℃; Hydrogenation;
With palladium on activated charcoal; water at 20℃; Hydrogenation;
levorotatory mesoinositol-tetraphosphoric acid

levorotatory mesoinositol-tetraphosphoric acid

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
With water at 130℃;
With sulfuric acid at 130℃;
phytic acid

phytic acid

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
With phytase
phytin

phytin

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
With mineral acid
With phytase
With water
With phytase
With sulfuric acid Hydrolysis;
myo-2-inosose
488-64-2

myo-2-inosose

water
7732-18-5

water

platinum

platinum

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
Hydrogenation;
salt of/the/ phytic acid

salt of/the/ phytic acid

D-myo-inositol
87-89-8

D-myo-inositol

tethelin

tethelin

D-myo-inositol
87-89-8

D-myo-inositol

Conditions
ConditionsYield
Hydrolysis;
D-myo-inositol
87-89-8

D-myo-inositol

phenylboronic acid
98-80-6

phenylboronic acid

rac-1:2,3:5,4:6-O1:O2,O3:O5,O4:O6-tris(phenylboronato)-myo-inositol
69814-44-4

rac-1:2,3:5,4:6-O1:O2,O3:O5,O4:O6-tris(phenylboronato)-myo-inositol

Conditions
ConditionsYield
at 95℃; for 1h;100%
D-myo-inositol
87-89-8

D-myo-inositol

cyclohexanone
108-94-1

cyclohexanone

rac-1,2-O-cyclohexylidene-myo-inositol
6763-47-9

rac-1,2-O-cyclohexylidene-myo-inositol

Conditions
ConditionsYield
Stage #1: D-myo-inositol; cyclohexanone With toluene-4-sulfonic acid In N,N-dimethyl-formamide; toluene at 122 - 136℃; for 10h; Condensation;
Stage #2: With ethanol; toluene-4-sulfonic acid at 20℃; for 48h; alcoholysis;
98%
With toluene-4-sulfonic acid97%
With toluene-4-sulfonic acid In N,N-dimethyl-formamide; toluene for 9h; Heating;93%
D-myo-inositol
87-89-8

D-myo-inositol

2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

L-1,2-O-isopropylidene-myo-inositol
128387-20-2

L-1,2-O-isopropylidene-myo-inositol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In dimethyl sulfoxide98%
D-myo-inositol
87-89-8

D-myo-inositol

acetic anhydride
108-24-7

acetic anhydride

inositol peracetate
1254-38-2

inositol peracetate

Conditions
ConditionsYield
With copper(II) perchlorate hexahydrate In neat (no solvent) at 20℃; for 0.166667h; Inert atmosphere;95%
iron(III) chloride at 28 - 32℃; for 0.166667h;86%
With zinc(II) chloride
D-myo-inositol
87-89-8

D-myo-inositol

n-decanoyl chloride
112-13-0

n-decanoyl chloride

Hexa-O-decanoyl-myo-inosit

Hexa-O-decanoyl-myo-inosit

Conditions
ConditionsYield
With trifluoroacetic acid for 15h; Ambient temperature;95%
D-myo-inositol
87-89-8

D-myo-inositol

benzoyl chloride
98-88-4

benzoyl chloride

Triethyl orthoacetate
78-39-7

Triethyl orthoacetate

2,4,6-tri-O-benzoyl-myo-inosityl 1,3,5-orthoacetate

2,4,6-tri-O-benzoyl-myo-inosityl 1,3,5-orthoacetate

Conditions
ConditionsYield
Stage #1: D-myo-inositol; Triethyl orthoacetate With toluene-4-sulfonic acid In N,N-dimethyl-formamide for 8h; Heating;
Stage #2: benzoyl chloride In pyridine at 20℃;
95%
D-myo-inositol
87-89-8

D-myo-inositol

benzoyl chloride
98-88-4

benzoyl chloride

1,3-di-O-benzoyl-myo-inositol
162062-52-4

1,3-di-O-benzoyl-myo-inositol

Conditions
ConditionsYield
With triethylamine; lithium chloride In N,N-dimethyl acetamide at -10℃; for 4h; regioselective reaction;95%
Stage #1: D-myo-inositol; benzoyl chloride With triethylamine; lithium chloride In N,N-dimethyl acetamide at -10℃; for 4h;
Stage #2: With pyridine; chloro-trimethyl-silane In N,N-dimethyl acetamide at 0℃; for 5h;
Stage #3: With trifluoroacetic acid In methanol; chloroform at 20℃; for 4h;
95%
D-myo-inositol
87-89-8

D-myo-inositol

propionic acid anhydride
123-62-6

propionic acid anhydride

Hexakispropionylmyoinositol
5776-50-1

Hexakispropionylmyoinositol

Conditions
ConditionsYield
With Cl(1-)*C5H14NO(1+)*3ZnCl2 In neat (no solvent) at 20℃; for 2h; Green chemistry;95%
Trimethyl orthoacetate
1445-45-0

Trimethyl orthoacetate

D-myo-inositol
87-89-8

D-myo-inositol

allyl bromide
106-95-6

allyl bromide

C18H30O9

C18H30O9

Conditions
ConditionsYield
Stage #1: Trimethyl orthoacetate; D-myo-inositol With toluene-4-sulfonic acid In N,N-dimethyl-formamide at 100℃; for 2h;
Stage #2: allyl bromide With sodium hydride In N,N-dimethyl-formamide at 20℃; for 3h; Further stages;
95%
D-myo-inositol
87-89-8

D-myo-inositol

benzoyl chloride
98-88-4

benzoyl chloride

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

(1R,3s,5r,6R,7S,8s,9S)-2,4,10-trioxaadamantane-6,8,9-triyl tribenzoate

(1R,3s,5r,6R,7S,8s,9S)-2,4,10-trioxaadamantane-6,8,9-triyl tribenzoate

Conditions
ConditionsYield
Stage #1: D-myo-inositol; orthoformic acid triethyl ester With toluene-4-sulfonic acid In N,N-dimethyl-formamide at 100℃;
Stage #2: benzoyl chloride In pyridine at 20℃;
94%
D-myo-inositol
87-89-8

D-myo-inositol

orthobenzoic acid trimethyl ester
707-07-3

orthobenzoic acid trimethyl ester

C13H14O6

C13H14O6

Conditions
ConditionsYield
With camphor-10-sulfonic acid In dimethyl sulfoxide Inert atmosphere;94%
With toluene-4-sulfonic acid In dimethyl sulfoxide at 100℃; for 5h; Inert atmosphere;
D-myo-inositol
87-89-8

D-myo-inositol

dimethyl sulfoxide
67-68-5

dimethyl sulfoxide

C11H16O8

C11H16O8

Conditions
ConditionsYield
With trichlorophosphate at 65℃; for 0.5h;92%
D-myo-inositol
87-89-8

D-myo-inositol

1,1,1-Trimethoxy-2,2-dimethyl-propane
97419-16-4

1,1,1-Trimethoxy-2,2-dimethyl-propane

3-tert-Butyl-2,4,10-trioxa-tricyclo[3.3.1.13,7]decane-6,8,9-triol

3-tert-Butyl-2,4,10-trioxa-tricyclo[3.3.1.13,7]decane-6,8,9-triol

Conditions
ConditionsYield
With camphor-10-sulfonic acid In dimethyl sulfoxide at 60℃; for 15h;91%
D-myo-inositol
87-89-8

D-myo-inositol

trimethyl orthoformate
149-73-5

trimethyl orthoformate

myo-inosytol 1,3,5-orthoformate

myo-inosytol 1,3,5-orthoformate

Conditions
ConditionsYield
With toluene-4-sulfonic acid In N,N-dimethyl-formamide Inert atmosphere;91%
toluene-4-sulfonic acid In DMF (N,N-dimethyl-formamide) at 120℃; for 7h;
Trimethyl orthoacetate
1445-45-0

Trimethyl orthoacetate

D-myo-inositol
87-89-8

D-myo-inositol

myo-inositol 1,3,5-orthoacetate

myo-inositol 1,3,5-orthoacetate

Conditions
ConditionsYield
With toluene-4-sulfonic acid In N,N-dimethyl-formamide at 90 - 100℃;91%
With toluene-4-sulfonic acid In N,N-dimethyl-formamide at 100℃; for 10h;10%
D-myo-inositol
87-89-8

D-myo-inositol

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

myo-Inositol orthoformate
98510-20-4

myo-Inositol orthoformate

Conditions
ConditionsYield
With Amberlyst 15 In N,N-dimethyl-formamide at 100℃; for 3h;90%
With toluene-4-sulfonic acid In N,N-dimethyl-formamide89%
With o-toluenesulfonic acid In N,N-dimethyl-formamide at 100℃; for 16h;84%
D-myo-inositol
87-89-8

D-myo-inositol

isobutyryl chloride
79-30-1

isobutyryl chloride

Hexakisisobutyrylmyoinositol
32077-77-3

Hexakisisobutyrylmyoinositol

Conditions
ConditionsYield
With pyridine; dmap at 80 - 85℃; for 1h;90%
D-myo-inositol
87-89-8

D-myo-inositol

orthobenzoic acid trimethyl ester
707-07-3

orthobenzoic acid trimethyl ester

myo-inositol 1,3,5-orthobenzoate

myo-inositol 1,3,5-orthobenzoate

Conditions
ConditionsYield
With camphor-10-sulfonic acid In dimethyl sulfoxide at 80℃; under 22.5023 - 30.003 Torr; for 3h;90%
With camphor-10-sulfonic acid In dimethyl sulfoxide at 80℃; for 5h;84%
With H2SO4 supported on silica In dimethyl sulfoxide at 60℃; under 300.03 Torr; for 0.5h; Inert atmosphere; Green chemistry;83%
D-myo-inositol
87-89-8

D-myo-inositol

acetic anhydride
108-24-7

acetic anhydride

1,3-di-O-acetyl-myo-inositol
1431370-12-5

1,3-di-O-acetyl-myo-inositol

Conditions
ConditionsYield
With dibutyltin diacetate; triethylamine; lithium chloride In N,N-dimethyl acetamide at -10℃; for 2h;90%
isocyanate de chlorosulfonyle
1189-71-5

isocyanate de chlorosulfonyle

D-myo-inositol
87-89-8

D-myo-inositol

myo-inositol hexacarbamate

myo-inositol hexacarbamate

Conditions
ConditionsYield
In acetonitrile at 20℃; for 1.5h; Cooling with ice;90%
D-myo-inositol
87-89-8

D-myo-inositol

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

myo-inositol-1,3,5-O-orthoformate

myo-inositol-1,3,5-O-orthoformate

Conditions
ConditionsYield
With toluene-4-sulfonic acid In N,N-dimethyl-formamide at 100℃; for 24h;89%
With toluene-4-sulfonic acid In N,N-dimethyl-formamide at 140℃; for 3h;87%
With toluene-4-sulfonic acid In N,N-dimethyl-formamide at 110℃; for 28h; Inert atmosphere;83%
D-myo-inositol
87-89-8

D-myo-inositol

trimethyl orthoformate
149-73-5

trimethyl orthoformate

myo-Inositol orthoformate
98510-20-4

myo-Inositol orthoformate

Conditions
ConditionsYield
With TSA In N,N-dimethyl-formamide at 110℃; for 5h;89%
In N,N-dimethyl-formamide70%
With toluene-4-sulfonic acid In N,N-dimethyl-formamide at 99.9℃; for 3h;
D-myo-inositol
87-89-8

D-myo-inositol

tert-butylchlorodiphenylsilane
58479-61-1

tert-butylchlorodiphenylsilane

1,3-di-O-tert-butyldiphenylsilyl-myo-inositol
1196789-46-4

1,3-di-O-tert-butyldiphenylsilyl-myo-inositol

Conditions
ConditionsYield
With pyridine In dimethyl sulfoxide at 20℃; for 72h; regioselective reaction;89%
With pyridine In dimethyl sulfoxide at 20℃; for 72h;89%
D-myo-inositol
87-89-8

D-myo-inositol

1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane
69304-37-6

1,3-Dichloro-1,1,3,3-tetraisopropyldisiloxane

1,6:3,4-bis-O-(tetraisopropyldisiloxane-1,3-diyl)-myo-inositol
123270-13-3

1,6:3,4-bis-O-(tetraisopropyldisiloxane-1,3-diyl)-myo-inositol

Conditions
ConditionsYield
With pyridine In dimethyl sulfoxide at 20℃; for 20h; regioselective reaction;88%
With pyridine In dimethyl sulfoxide at 20℃; for 20h;88%
With pyridine Ambient temperature;66%
D-myo-inositol
87-89-8

D-myo-inositol

pivaloyl chloride
3282-30-2

pivaloyl chloride

1,3-di-O-pivaloyl-myo-inositol
1196789-44-2

1,3-di-O-pivaloyl-myo-inositol

Conditions
ConditionsYield
With triethylamine; lithium chloride In N,N-dimethyl acetamide at 0℃; for 10h; regioselective reaction;88%
With triethylamine; lithium chloride In N,N-dimethyl acetamide at 0℃; for 10h;88%

87-89-8Relevant articles and documents

Bellmann,Jacot-Guillarmod

, p. 773,775 (1973)

Forced degradation of L-(+)-bornesitol, a bioactive marker of Hancornia speciosa: Development and validation of stability indicating UHPLC-MS method and effect of degraded products on ACE inhibition

Gomes, José Hugo de Sousa,da Silva, Grazielle Caroline,C?rtes, Steyner F.,de Pádua, Rodrigo Maia,Braga, Fern?o Castro

, p. 31 - 38 (2018)

The antihypertensive activity of the medicinal plant Hancornia speciosa has been previously demonstrated by us, being the activity ascribed to polyphenols and cyclitols like L-(+)-bornesitol. We herein evaluated the stability of the bioactive marker bornesitol submitted to forced degradation conditions. Bornesitol employed in the study was isolated from H. speciosa leaves. An UHPLC-ESI-MS/MS method was developed to investigate bornesitol stability based on MRM (Multiple Reaction Monitoring) acquisition mode and negative ionization mode, employing both specific (m/z 193 → 161 Da) and confirmatory (m/z 193 → 175 Da) transitions. A gradient elution of 0.1% formic acid in water and acetonitrile was performed on a HILIC column. The method was validated and showed adequate linearity (r2 > 0.99), selectivity, specificity, accuracy, and precision (RSD 2.9%). The method was robust for deliberate variations on dessolvation temperature, but not for changes in the flow rate and dessolvation gas. The results from the stability studies allowed us to classify bornesitol as labile for acidic and alkaline hydrolysis, but as very stable for oxidative and neutral hydrolysis exposure. Bornesitol was categorized as practically stable under photolysis degradation, whereas a considerable reduction on its contents was induced by metal ions and thermolysis exposure. Degraded samples from neutral hydrolysis and thermolysis were assayed in vitro for ACE inhibition and showed a substantial decrease in biological activity as compared to intact bornesitol. myo-Inositol was identified as the major degradation products in both matrices. This is the first report on bornesitol stability under different stress conditions and the obtained data are relevant for the development and quality control of standardized products from H. speciosa leaves.

METHODS OF EXTRACTING PHOSPHORUS FROM DISTILLATES

-

Paragraph 0029; 0099, (2016/11/28)

Methods of processing distillates, methods of removing at least some portion of total phosphorus in a distillate, methods of removing at least some portion of the soluble inorganic phosphorus, phytate phosphorus, or some combination thereof in a distillate, methods for obtaining phytate from distillates, methods for producing phytate derivatives and combinations thereof.

Elaboration of the ether cleaving ability and selectivity of the classical Pearlman's catalyst [Pd(OH)2/C]: Concise synthesis of a precursor for a myo-inositol pyrophosphate

Mart, Alson,Shashidhar, Mysore S.

, p. 9769 - 9776,8 (2012/12/11)

The cleavage of propargyl, allyl, benzyl, and PMB ethers by Pd(OH) 2/C can be tuned in that order, by varying the reaction conditions. Other moieties such as C-C double bonds, esters, trityl ether, p-bromo and p-nitrobenzyl ethers are stable to these reaction conditions. Cleavage of allyl ethers can be made catalytic by using 1:1 mixture of Pd(OH)2/C and Pd/C. The synthetic potential of the selective ether cleaving ability of Pd(OH)2/C, essentially under neutral conditions, has been demonstrated by an efficient synthesis of a precursor for the preparation of an inositol pyrophosphate derivative.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 87-89-8